• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

链激酶激活人纤溶酶原的动力学机制

Kinetic mechanism of the activation of human plasminogen by streptokinase.

作者信息

Kosow D P

出版信息

Biochemistry. 1975 Oct 7;14(20):4459-65. doi: 10.1021/bi00691a018.

DOI:10.1021/bi00691a018
PMID:126078
Abstract

A method of determining the initial rate of plasminogen activation has been developed. The method has been used to investigate the mechanism of activation of human plasminogen by streptokinase. Plasmin formation follows saturation kinetics. Inhibition of plasmin formation by epsilon-aminocaproic acid is uncompetitive with a Ki of 0.6 mM. A model consistent with the data is that streptokinase induces a conformational change in the plasminogen molecule, producing an active center which cleaves an internal peptide bond to produce plasmin. Thus, streptokinase functions as a catalytic allosteric effector.

摘要

一种测定纤溶酶原激活初始速率的方法已被开发出来。该方法已被用于研究链激酶激活人纤溶酶原的机制。纤溶酶的形成遵循饱和动力学。ε-氨基己酸对纤溶酶形成的抑制作用是非竞争性的,抑制常数(Ki)为0.6 mM。与这些数据相符的模型是,链激酶诱导纤溶酶原分子发生构象变化,产生一个活性中心,该活性中心切割一个内部肽键以产生纤溶酶。因此,链激酶起催化变构效应物的作用。

相似文献

1
Kinetic mechanism of the activation of human plasminogen by streptokinase.链激酶激活人纤溶酶原的动力学机制
Biochemistry. 1975 Oct 7;14(20):4459-65. doi: 10.1021/bi00691a018.
2
Activation of human plasminogen by equimolar levels of streptokinase.等摩尔水平的链激酶对人纤溶酶原的激活作用。
J Biol Chem. 1977 Jan 25;252(2):492-8.
3
Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.关于人纤溶酶原、Val442-纤溶酶原、纤溶酶及纤溶酶衍生的轻(B)链的链激酶复合物的流体动力学研究
Biochemistry. 1984 May 22;23(11):2384-7. doi: 10.1021/bi00306a010.
4
[Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].[L-赖氨酸对酯酶的抑制作用、纤溶酶-链激酶激活复合物的激活剂及纤溶活性]
Bioorg Khim. 1994 Feb;20(2):182-9.
5
Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
Eur J Drug Metab Pharmacokinet. 2003 Oct-Dec;28(4):315-20. doi: 10.1007/BF03220185.
6
Mechanism of activation of human plasminogen by the activator complex, streptokinase-plasmin.链激酶 - 纤溶酶激活复合物激活人纤溶酶原的机制
J Biol Chem. 1978 Feb 25;253(4):1090-4.
7
Streptokinase-dependent delayed activation of horse plasminogen.链激酶依赖性马纤溶酶原的延迟激活。
Biochim Biophys Acta. 1982 Dec 6;709(1):19-27. doi: 10.1016/0167-4838(82)90416-2.
8
A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function.一种具有纤溶酶原激活剂功能的非抗原性共价链激酶 - 聚乙二醇复合物。
J Clin Invest. 1985 Feb;75(2):413-9. doi: 10.1172/JCI111715.
9
Regulation of nonproteolytic active site formation in plasminogen.纤溶酶原中非蛋白水解活性位点形成的调控。
Biochemistry. 2007 Jul 31;46(30):8879-87. doi: 10.1021/bi602591g. Epub 2007 Jul 7.
10
Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity.
Clin Chem Lab Med. 2006;44(2):213-9. doi: 10.1515/CCLM.2006.039.

引用本文的文献

1
Pathogen activators of plasminogen.纤溶酶原的病原体激活剂。
J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S106-14. doi: 10.1111/jth.12939.
2
Streptokinase--the drug of choice for thrombolytic therapy.链激酶——溶栓治疗的首选药物。
J Thromb Thrombolysis. 2007 Feb;23(1):9-23. doi: 10.1007/s11239-006-9011-x.
3
Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
Eur J Drug Metab Pharmacokinet. 2003 Oct-Dec;28(4):315-20. doi: 10.1007/BF03220185.
4
Ionic modulation of the effects of heparin and 6-aminohexanoic acid on plasminogen activation by streptokinase: the role of ionic strength, divalent cations and chloride.肝素和6-氨基己酸对链激酶激活纤溶酶原作用的离子调节:离子强度、二价阳离子和氯离子的作用
Eur J Drug Metab Pharmacokinet. 2003 Apr-Jun;28(2):161-6. doi: 10.1007/BF03190506.
5
Circulatory concentrations of fibrinolytic species during thrombolytic therapy estimated by stirred-tank reactor analysis.通过搅拌釜反应器分析估算溶栓治疗期间纤溶物质的循环浓度。
Pharm Res. 1997 Aug;14(8):1051-7. doi: 10.1023/a:1012157429573.
6
Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis.
J Mol Med (Berl). 1996 Aug;74(8):463-9. doi: 10.1007/BF00217522.
7
ATP-regulated activity of the plasmin-streptokinase complex: a novel mechanism involving phosphorylation of streptokinase.纤溶酶-链激酶复合物的ATP调节活性:一种涉及链激酶磷酸化的新机制。
Biochem J. 1996 Jan 1;313 ( Pt 1)(Pt 1):171-7. doi: 10.1042/bj3130171.
8
Kinetic behaviour of zymogen activation processes in the presence of an inhibitor.存在抑制剂时酶原激活过程的动力学行为
Biochem J. 1993 Mar 1;290 ( Pt 2)(Pt 2):463-70. doi: 10.1042/bj2900463.
9
Transient phase kinetics of activation of human plasminogen.人纤溶酶原激活的瞬态动力学
Bull Math Biol. 1986;48(2):149-66. doi: 10.1007/BF02460020.
10
The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase.ε-氨基己酸和氯离子对人尿激酶激活人[Glu1]纤溶酶原的相互作用
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4031-4. doi: 10.1073/pnas.84.12.4031.